Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 2, 2011, Pages 261-269

  Tang, Eva H C ^a,b   Shvartz, Eugenia ^a   Shimizu, Koichi ^a   Rocha, Viviane Z ^a   Zheng, Chunyu ^a   Fukuda, Daiju ^a   Shi, Guo Ping ^a   Sukhova, Galina ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

aneurysms; eicosanoids; prostaglandins; receptors; transplantation

Indexed keywords

ANGIOTENSIN II; ELASTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL AGGREGATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPERLIPIDEMIA; IN VIVO STUDY; INTRACELLULAR SIGNALING; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHEMOKINE CCL2; ELASTIN; FEMALE; GENE DELETION; HYPERLIPIDEMIAS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; RECEPTORS, LDL; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RISK FACTORS;

EID: 79551479091     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.216580     Document Type: Article

References (41)

1. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006;26:987-994.
2. Middleton RK, Lloyd GM, Bown MJ, Cooper NJ, London NJ, Sayers RD. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg. 2007;45:574-580.
3. Lindeman JH, Abdul-Hussien H, Schaapherder AF, Van Bockel JH, Von der Thüsen JH, Roelen DL, Kleemann R. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneu-rismal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin Sci (Lond). 2008; 114:687-697.
4. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem. 2007; 282:11613-11617.
5. 2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Surg. 1999;25:810-815.
6. 2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation. 1999;100:48-54.
7. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, Pure E, FitzGerald GA. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation. 2008;117:1302-1309.
8. 2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. J Vasc Surg. 2003;38:354-359.
9. Hristovska AM, Rasmussen LE, Hansen PB, Nielsen SS, Nusing RM, Narumiya S, Vanhoutte P, Skott O, Jensen BL. Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension. 2007;50:525-530.
10. Van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med. 1995;181:775-779.
11. Hilkens C, Snijders A, Vermeulen H, van der Meide P, Wierenga E, Kapsenberg M. Accessory cell-derived interleukin-12 and prostaglandin E2 determine the level of interferon-gamma produced by activated human CD4+ T cells. Ann N Y Acad Sci. 1996;795:349-350. (Pubitemid 27029588)
12. 2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem. 2002;277: 44147-44154.
13. 2 receptor 4 activation in murine cardiac transplantation. Transplantation. 2009;87: 1645-1653.
14. 4. Circulation. 2004;109:2462-2468.
15. 2 receptor EP4 improves cardiac function after myocardial ischaemia/ reperfusion injury. Cardiovasc Res. 2009;81:123-132.
16. 2-dependent plaque instability. Circulation. 2001;104: 921-927.
17. Cipollone F, Fazia ML, Iezzi A, Cuccurullo C, De Cesare D, Ucchino S, Spigonardo F, Marchetti A, Buttitta F, Paloscia L, Mascellanti M, Cuccurullo F, Mezzetti A. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol. 2005;9:1925-1931.
18. 2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J Biol Chem. 2006;281:3321-3328.
19. 2 in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol. 2005;67:1061-1069.
20. Babaev VR, Chew JD, Ding L, Davis S, Breyer MD, Breyer RM, Oates JA, Fazio S, Linton MF. Macrophages EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab. 2008;8:492-501.
21. Collin J, Walton J, Araujo L, Lindsell D. Oxford screening programme for abdominal aortic aneurysm in men aged 65 to 74 years. Lancet. 1988;2:613-615.
22. Scott RAP, Ashton HA, Kay DN. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over 6 years. Br J Surg. 1991;78:1122-1125.
23. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15: 1145-1151.
24. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H, Airaksinen J, Leinonen M, Saikku PT, Juvonen T. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneu-rysm. Arterioscler Thromb Vasc Biol. 1997;17:2843-2847.
25. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, Roelofs KJ, Woodrum DT, Ennis TL, Henke PK, Stanley JC, Thompson RW, Upchurch GR Jr. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 2005;112:232-240.
26. Keeling WB, Armstrong PA, Stone PA, Bandyk DF, Shames ML. An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg. 2005;39: 457-464.
27. Gitlin JM, Trivedi DB, Langenbach R, Loftin CD. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res. 2007;73:227-236.
28. Daugherty A, Cassis L. Chronic angiotensin II infusion promotes athero-gensis in low density lipoprotein receptor-/- mice. Ann N Y Acad Sci. 1999;982:108-118.
29. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol. 2001;134:865-870.
30. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Mastuoka T, Ushikubi F, Hirose M, Tanaka T, Yoshida N, Narumiya S, Ichikawa A. Patent ductus arteriosus and neonatal death in prostaglan-din receptor EP4-deficient mice. Biochem Biophy Res Comm. 1998; 246:7-12.
31. Manning MW, Cassis LA, Huang J, Szilvassy SJ, Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med. 2002;7:45-54.
32. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA. Orchi-ectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E deficient mice. Endocrinology. 2004;145: 3866-3872.
33. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA. Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2008;28:1251-1256.
34. Echeverría González FM, Cuasnicú PS, Blaquier JA. Identification of androgen-dependent glycoproteins in the hamster epididymis and their association with spermatozoa. J Reprod Fertil. 1982;64:1-7.
35. Hinton AC, Grigsby PL, Pitzer BA, Brockman DE, Ittenbach RF, Hinton RB, Myatt L. Hormonal regulation of prostaglandin E2 receptors: localization and expression in rat cervical tissue. Reprod Sci. 2010;17: 136-146.
36. Terada N, Shimizu Y, Kamba T, Inoue T, Maeno A, Kobayashi T, Nakamura E, Kamoto T, Kanaji T, Maruyama T, Mikami Y, Toda Y, Matsuoka T, Okuno Y, Tsujimoto G, Narumiya S, Ogawa O. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer Res. 2010;70: 1606-1615.
37. Sirianni R, Chimento A, De Luca A, Zolea F, Carpino A, Rago V, Maggiolini M, Andò S, Pezzi V. Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells. J Biol Chem. 2009;284:28905-28916.
38. Kim JY, Han EH, Kim HG, Oh KN, Kim SK, Lee KY, Jeong HG. Bisphenol A-induced aromatase activation is mediated by cyclooxygen-ase-2 up-regulation in rat testicular Leydig cells. Toxicol Lett. 2010;193: 200-208.
39. 4 subtype suppresses food intake in mice. Prostag Other Lipids Med. 2006;81:31-36.
40. 4 receptor in mice. FEBS Lett. 2008;582: 773-777.
41. 2 suppression of 3T3-L1 adipocyte differentiation. Biochem Biophy Res Comm. 2004;322:911-917.